CY1502A - Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or-4-one derivatives - Google Patents
Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or-4-one derivativesInfo
- Publication number
- CY1502A CY1502A CY1502A CY150283A CY1502A CY 1502 A CY1502 A CY 1502A CY 1502 A CY1502 A CY 1502A CY 150283 A CY150283 A CY 150283A CY 1502 A CY1502 A CY 1502A
- Authority
- CY
- Cyprus
- Prior art keywords
- hydroxypyrid
- derivatives
- substituted
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8208608 | 1982-03-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1502A true CY1502A (en) | 1990-08-03 |
Family
ID=10529232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY1502A CY1502A (en) | 1982-03-24 | 1983-03-24 | Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or-4-one derivatives |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4840958A (zh) |
| EP (1) | EP0093498B1 (zh) |
| JP (3) | JPS58174319A (zh) |
| CY (1) | CY1502A (zh) |
| DE (2) | DE19975062I1 (zh) |
| GR (1) | GR78491B (zh) |
| HK (1) | HK6190A (zh) |
| NL (1) | NL990031I2 (zh) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0305646B1 (en) * | 1983-03-24 | 1996-11-13 | Btg International Limited | 3-Hydroxypyrid-4-ones and pharmaceutical compositions |
| GB8308055D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| GB8308054D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| GB8325494D0 (en) * | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
| US4912118A (en) * | 1983-09-23 | 1990-03-27 | National Research Development Corporation | Pharmaceutical compositions |
| USRE34313E (en) * | 1983-09-23 | 1993-07-13 | National Research Development Corporation | Pharmaceutical compositions |
| EP0335745A1 (en) * | 1988-03-31 | 1989-10-04 | The Royal Free Hospital School Of Medicine | Process for producing pyrid-4-ones |
| GB8910521D0 (en) * | 1989-05-08 | 1989-06-21 | Nat Res Dev | The stabilization of organic compounds |
| US5298525A (en) * | 1992-11-23 | 1994-03-29 | University Technologies International, Inc. | Diabetes prevention and treatment |
| US6046219A (en) * | 1995-01-20 | 2000-04-04 | Cornell Research Foundation, Inc. | Method for the treatment of conditions mediated by collagen formation together with cell proliferation by application of inhibitors of protein hydroxylation |
| US5849587A (en) * | 1995-06-09 | 1998-12-15 | Cornell Research Foundation, Inc. | Method of inhibiting viral replication in eukaryotic cells and of inducing apoptosis of virally-infected cells |
| ATE273702T1 (de) | 1995-06-10 | 2004-09-15 | Vitra Pharmaceuticals Ltd | Eisenverbindungen, zusammensetzungen, herstellungsverfahren und verwendungen davon |
| US6004986A (en) * | 1997-05-08 | 1999-12-21 | The University Of Virginia Patent Foundation | Method for treating cerebral vasospasm and cerebral ischemia using iron chelators and pharmaceutical compositions therefor |
| US6767741B1 (en) * | 1999-08-27 | 2004-07-27 | Invitrogen Corporation | Metal binding compounds and their use in cell culture medium compositions |
| IL135884A (en) * | 2000-04-30 | 2005-08-31 | Yissum Res Dev Co | Method for measuring non-transferrin bound iron |
| US7135196B2 (en) * | 2000-09-19 | 2006-11-14 | Vitra Pharmaceuticals Limited | Iron compositions |
| US6426418B1 (en) | 2001-11-02 | 2002-07-30 | Apotex, Inc. | Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide |
| GB0211500D0 (en) | 2002-05-18 | 2002-06-26 | Vitra Pharmaceuticals Ltd | Method of forming iron hydroxypyrone compounds |
| CA2504512A1 (en) | 2002-10-30 | 2004-05-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Molecules and methods using same for measuring non-transferrin bound iron |
| CA2505476C (en) | 2002-11-07 | 2015-05-26 | Technion Research And Development Foundation Ltd. | Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| CA2488034C (en) * | 2004-11-19 | 2009-10-06 | Apotex Inc. | Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues |
| EP2542077A4 (en) * | 2010-03-04 | 2013-08-21 | Merck Sharp & Dohme | CATECHOL O-METHYL TRANSFERASE INHIBITORS AND USE THEREOF IN THE TREATMENT OF PSYCHOTIC DISORDERS |
| GB201007209D0 (en) | 2010-04-29 | 2010-06-16 | King S College London | Compound |
| WO2012137202A1 (en) | 2011-04-05 | 2012-10-11 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci) |
| KR102522060B1 (ko) | 2016-11-07 | 2023-04-14 | 아뷰터스 바이오파마 코포레이션 | 치환된 피리디논 함유 트리시클릭 화합물, 및 그의 사용 방법 |
| WO2019177937A1 (en) | 2018-03-12 | 2019-09-19 | Arbutus Biopharma, Inc. | Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same |
| TW202010499A (zh) | 2018-04-12 | 2020-03-16 | 加拿大商愛彼特生物製藥公司 | 經取代的吡啶酮之三環化合物的製備方法 |
-
1983
- 1983-03-23 GR GR70868A patent/GR78491B/el unknown
- 1983-03-24 CY CY1502A patent/CY1502A/xx unknown
- 1983-03-24 JP JP58049677A patent/JPS58174319A/ja active Granted
- 1983-03-24 EP EP83301659A patent/EP0093498B1/en not_active Expired
- 1983-03-24 DE DE1999175062 patent/DE19975062I1/de active Pending
- 1983-03-24 JP JP58049676A patent/JPS58174318A/ja active Granted
- 1983-03-24 DE DE8383301659T patent/DE3367849D1/de not_active Expired
-
1986
- 1986-11-20 US US06/933,338 patent/US4840958A/en not_active Expired - Lifetime
-
1990
- 1990-01-25 HK HK61/90A patent/HK6190A/xx not_active IP Right Cessation
-
1992
- 1992-02-18 JP JP4030887A patent/JPH0757749B2/ja not_active Expired - Lifetime
-
1999
- 1999-10-06 NL NL990031C patent/NL990031I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0757749B2 (ja) | 1995-06-21 |
| DE19975062I1 (de) | 2003-09-04 |
| JPH0515693B2 (zh) | 1993-03-02 |
| JPS58174319A (ja) | 1983-10-13 |
| NL990031I1 (nl) | 1999-12-01 |
| JPH0460987B2 (zh) | 1992-09-29 |
| HK6190A (en) | 1990-02-02 |
| JPS58174318A (ja) | 1983-10-13 |
| GR78491B (zh) | 1984-09-27 |
| US4840958A (en) | 1989-06-20 |
| DE3367849D1 (en) | 1987-01-15 |
| EP0093498A2 (en) | 1983-11-09 |
| EP0093498A3 (en) | 1984-07-11 |
| NL990031I2 (nl) | 2000-04-03 |
| JPH0680636A (ja) | 1994-03-22 |
| EP0093498B1 (en) | 1986-11-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3367849D1 (en) | Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or -4-one derivatives | |
| GB8326565D0 (en) | Pharmaceutical compositions | |
| GB8327612D0 (en) | Pharmaceutical compositions | |
| CY1574A (en) | Pharmaceutical compositions containing 1-hydroxypyramid-2-one derivatives | |
| ZA833781B (en) | Pharmaceutical compositions | |
| EP0093551A3 (en) | Pharmaceutical composition | |
| GB2118176B (en) | Pharmaceutical compositions | |
| GB2117766B (en) | Pharmaceutical compositions | |
| GB8324133D0 (en) | Pharmaceutical compositions | |
| GB8429749D0 (en) | Pharmaceutical compositions | |
| GB8313814D0 (en) | Pharmaceutical compositions | |
| IL69294A0 (en) | Pharmaceutical compositions containing sugar derivatives | |
| GB8329700D0 (en) | Anti-haemophilic pharmaceutical composition | |
| DE3377696D1 (en) | Pharmaceutical compositions | |
| US4594359B1 (en) | Pharmaceutical compositions | |
| GB8328896D0 (en) | Pharmaceutical composition | |
| GB2114001B (en) | Nasel pharmaceutical compositions | |
| IL67881A0 (en) | Pharmaceutical compositions including certain cholecalciferol derivatives | |
| GB8305028D0 (en) | Pharmaceutical compositions | |
| GB8314736D0 (en) | Pharmaceutical compositions | |
| GB8330810D0 (en) | Pharmaceutical compositions | |
| GB8331068D0 (en) | Pharmaceutical compositions | |
| GB8329391D0 (en) | Pharmaceutical compositions | |
| GB8314540D0 (en) | Pharmaceutical composition | |
| DE3372706D1 (en) | Pharmaceutical compositions |